Isolation and characterization of fourteen novel putative and nine known target genes of the p53 family

Cancer Biology and Therapy

Volumn 2, Issue 1, 2003, Pages 56-63

  Chen, Xinbin ^a   Liu, Gang ^a   Zhu, Jianhui ^a   Jiang, Jiayuan ^a   Nozell, Susan ^a   Willis, Amy ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Apoptosis; Cell cycle arrest; DNA damage; p53; p63; p73

Indexed keywords

DNA; DNA BINDING PROTEIN; NUCLEAR PROTEIN; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIVISION; DNA DAMAGE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MUTATION; NEOPLASM; NORTHERN BLOTTING; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL CYCLE; CELL DIVISION; DNA DAMAGE; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; MUTATION; NEOPLASM PROTEINS; NEOPLASMS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0037484558     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.180     Document Type: Article

References (66)

1. Willis AC, Chen X. The promise and obstacle of p53 as a cancer therapeutic agent. Curr Mol Med 2002; 2:329-45. (Pubitemid 35452883)
2. El-Deiry WS. Regulation of p53 downstream genes. Semin Cancer Biol 1998; 8:345-57. (Pubitemid 29131356)
3. Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev 1996; 10:1054-72.
4. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-25. (Pubitemid 23346378)
5. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9:1799-805. (Pubitemid 24163411)
6. Nakano K., Balint E, Ashcroft M, Vousden KH. A ribonucleotide reductase gene is a transcriptional target of p53 and p73. Oncogene 2000; 19:4283-9.
7. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, et al. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 2000; 404:42-9. (Pubitemid 30143125)
8. Wu GS, Burns TF, McDonald ER, 3rd, Jiang W, Meng R, Krantz I, et al. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene [letter]. Nat Genet 1997; 17:141-3
9. Zhu J, Chen X. MCG10, a novel p53 target gene that encodes a KH domain RNA binding protein, is capable of inducing apoptosis and cell cycle arrest in G2-M. Mol Cell Biol 2000; 20: 5602-18. (Pubitemid 30482895)
10. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, et al. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 2000; 102:849-62.
11. Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 2001; 7:683-94 (Pubitemid 32706359)
12. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 2001; 7:673-82 (Pubitemid 32706358)
13. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-10.
14. Vousden KH. p53. Death star. Cell 2000; 103:691-4.
15. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995; 82:675-84
16. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 1995; 377:552-7
17. Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene 2001; 20:1803-15 (Pubitemid 32458690)
18. Hermeking H, Lengauer C, Polyak K, He T-C, Zhang L, Thiagalingam S, et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1997; 1:3-11. (Pubitemid 127376388)
19. Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, et al. GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci USA 1999; 96:3706-11. (Pubitemid 29168974)
20. Chen X. The p53 family: same response, different signals? Mol Med Today 1999; 5:387-92.
21. Lin J, Teresky AK, Levine AJ. Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants. Oncogene 1995; 10:2387-90.
22. Haupt Y, Rowan S, Shaulian E, Vousden KH, Oren M. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev 1995; 9:2170-83.
23. Chen X, Ko LJ, Jayaraman L, Prives C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 1996; 10:2438-51. (Pubitemid 26341879)
24. Walker KK, Levine AJ. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA 1996; 93:15335-40. (Pubitemid 27009601)
25. Sakamuro D, Sabbatini P, White E, Prendergast GC. The polyproline region of p53 is required to activate apoptosis but not growth arrest.Oncogene 1997; 15:887-98.
26. Zhu J, Jiang J, Zhou W, Zhu K, Chen X. Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity. Oncogene 1999; 18:2149-55. (Pubitemid 29178584)
27. Venot C, Maratrat M, Dureuil C, Conseiller E, Bracco L, Debussche L. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression [In Process Embo J 1998; 17:4668-79.
28. Zhu J, Zhang S, Jiang J, Chen X. Definition of the p53 functional domains necessary for inducing apoptosis. J Biol Chem 2000; 275:39927-34. (Pubitemid 32064614)
29. Venot C, Maratrat M, Sierra V, Conseiller E, Debussche L. Definition of a p53 transactivation function-deficient mutant and characterization of two independent p53 transactivation subdomains. Oncogene 1999; 18:2405-10. (Pubitemid 29192719)
30. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90:809-19 (Pubitemid 27357971)
31. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998; 2:305-16
32. Zhu J, Jiang J, Zhou W, Chen X. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res 1998; 58:5061-5. (Pubitemid 28521161)
33. Jost CA, Marin MC, Kaelin WG, Jr. p73 is a human p53-related protein that can induce apoptosis [see comments]. Nature 1997; 389:191-4. (Pubitemid 27400602)
34. Osada M, Ohba M, Kawahara C, Ishioka C, Kanamaru R, Katoh I, et al. Cloning and functional analysis of human p51, which structurally and functionally resembles p53 [In Process Citation]. Nat Med 1998; 4:839-43. (Pubitemid 28331028)
35. Trink B, Okami K, Wu L, Sriuranpong V, Jen J, Sidransky D. A new human p53 homologue. Nat Med 1998; 4:747-8.
36. Dohn M, Zhang S, Chen X. , p63a and DNp63a can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 2001; 20:3193-205. (Pubitemid 32553672)
37. Zhu J, Zhou W, Jiang J, Chen X. Identification of a novel p53 functional domain that is necessary for mediating apoptosis. J Biol Chem 1998; 273:13030-6. (Pubitemid 28246867)
38. Zhu J, Nozell S, Wang J, Jiang J, Zhou W, Chen X. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner. Oncogene 2001; 20:4050-7. (Pubitemid 32681610)
39. Liu G, Chen X. The ferrodoxin reductase gene is regulated by the p53 family and sensitive cells to oxidative stress-induced apoptosis. Oncogene 2002; 21:7195-204. (Pubitemid 35305606)
40. Wang J, Shou J, Chen X. Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53. Oncogene 2000; 19:1843-8. (Pubitemid 30200990)
41. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994; 54:1169-74. (Pubitemid 24108052)
42. Rouault JP, Falette N, Guehenneux F, Guillot C, Rimokh R, Wang Q, et al. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 1996; 14:482-6. (Pubitemid 26414597)
43. Hwang PM, Bunz F, Yu J, Rago C, Chan TA, Murphy MP, et al. Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med 2001; 7:1111-7 (Pubitemid 33010018)
44. Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW, Vogelstein B. Identification and classification of p53-regulated genes. Proc Natl Acad Sci USA 96:14517-22.
45. Hauptmann R, Maurer-Fogy I, Krystek E, Bodo G, Andree H, Reutelingsperger, CP.Vascular anticoagulant beta: a novel human Ca2+/phospholipid binding protein that inhibits coagulation and phospholipase A2 activity. Its molecular cloning, expression and comparison with VAC-alpha. Eur J Biochem 1989; 185:63-71. (Pubitemid 19262323)
46. Sarkar A, Yang P, Fan YH, Mu ZM, Hauptmann R, Adolf GR, et al. Regulation of the expression of annexin VIII in acute promyelocytic leukemia. Blood 1994; 84:279-86. (Pubitemid 24193831)
47. Chang KS, Wang G, Freireich EJ, Daly M, Naylor SL, Trujillo JM, et al. Specific expression of the annexin VIII gene in acute promyelocytic leukemia. Blood 1992; 79:1802-10.
48. Engelman JA, Zhang X, Galbiati F, Volonte D, Sotgia F, Pestell RG, et al. Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy. Am J Hum Genet 1998; 63:1578-87. (Pubitemid 30415719)
49. Galbiati F, Volonte D, Gil O, Zanazzi G, Salzer JL, Sargiacomo M, et al. Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. Proc Natl Acad Sci USA 1998; 95:10257-62.
50. Galbiati F, Volonte D, Liu J, Capozza F, Frank PG, Zhu L, et al. Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell 2001; 12: 2229-44
51. Ponnambalam S, Jackson AP, LeBeau MM, Pravtcheva D, Ruddle FH, et al. Chromosomal location and some structural features of human clathrin light-chain genes (CLTA and CLTB). Genomics 1994; 24:440-4.
52. Keyse SM, Emslie EA.Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature 1992; 359:644-7.
53. Alessi DR, Smythe C, Keyse SM. The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts. Oncogene 1993; 8:2015-20. (Pubitemid 23212436)
54. Sanchez-Perez I, Martinez-Gomariz M, Williams D, Keyse SM, Perona R. CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin. Oncogene 2000; 19:5142-52.
55. Takekawa M, Adachi M, Nakahata A, Nakayama I, Itoh F, Tsukuda H, et al. p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. Embo J 2000; 19:6517-26.
56. Woodcock EA, Wang BH, Arthur JF, Lennard A, Matkovich SJ, et al .Inositol polyphosphate 1-phosphatase is a novel antihypertrophic factor. J Biol Chem 2002; 277:22734-42. (Pubitemid 34967253)
57. Jiang R, Lan Y, Chapman HD, Shawber C, Norton CR, et al. Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice. Genes Dev 1998; 12:1046-57
58. Sasaki Y, Ishida S, Morimoto I, Yamashita T, Kojima T, Kihara C, et al. The p53 family member genes are involved in the Notch signal pathway. J Biol Chem 2002; 277:719-24. (Pubitemid 34952112)
59. Araki T, Milbrandt J. Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth. Neuron 1996; 17:353-61. (Pubitemid 26296161)
60. Jansen GA, Mihalik SJ, Watkins PA, Moser HW, Jakobs C, Denis S, et al. Phytanoyl-CoA hydroxylase is present in human liver, located in peroxisomes, and deficient in Zellweger syndrome: direct, unequivocal evidence for the new, revised pathway of phytanic acid alpha-oxidation in humans. Biochem Biophys Res Commun 1996; 229:205-10. (Pubitemid 27013732)
61. Skelly RH, Korbonits M, Grossman A, Besser GM, Monson JP, Geddes JF, et al. Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased alpha-subunit secretion. J Clin Endocrinol Metab 2000; 85:2537-42. (Pubitemid 32269212)
62. Szeto DP, Rodriguez-Esteban C, Ryan AK, O'Connell SM, Liu F, Kioussi C, et al. Role of the Bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development. Genes Dev 1999; 13:484-94. (Pubitemid 29108763)
63. Woods A, Cheung PC, Smith FC, Davison MD, Scott J, Beri RK, et al. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. J Biol Chem 1996; 271:10282-90.
64. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 2002; 296:1880-2. (Pubitemid 34596276)
65. van der Loop FT, Schaart G, Timmer ED, Ramaekers FC, van Eys GJ. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J Cell Biol 1996; 134:401-11. (Pubitemid 26250708)
66. Kannan K, Amariglio N, Rechavi G, Jakob-Hirsch J, Kela I, Kaminski N, et al. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 2001; 20:2225-34. (Pubitemid 32531280)